Pharmaron Holds Seventh Annual Symposium on Synthetic and Medicinal Chemistry

Beijing China, September 19, 2017, Pharmaron held its 7th Symposium on Synthetic and Medicinal Chemistry on September 16. Eight world-renowned professors and industry leaders from Europe, China and the United States, presented to hundreds of Pharmaron scientists  and partners.

The presenters discussed latest advancements in synthetic and medicinal chemistry, which included newly developed synthetic methodologies, total synthesis of highly complex natural products and design and synthesis of biologically active molecules that meet unmet medical needs.

 “Continuous learning is how we stay ahead,” said Dr. Boliang Lou, Chairman & CEO, Pharmaron. “Our wonderful presenters provided us with chemistry updates as well as inspiration to stay innovative.”

Symposium Speakers: 

  • Dr. Markus Follmann, Director, Bayer AG, Germany
  • Dr. Andras Horvath, Johnson & Johnson, Belgium
  • Prof. Jinbo Hu, Shanghai Institute of Organic Chemistry, China
  • Dr. Jianguo Ji, AbbVie, USA
  • Dr. Garry Pairaudeau, AstraZeneca, UK
  • Prof. Sarah Reisman, California Institute of Technology, USA
  • Prof. Barry Trost, Stanford University, USA
  • Dr. Petr Vachal, Associate VP, Discovery Chemistry, MSD, USA